ARTICLE | Company News
Immunicon other research news
March 6, 2000 8:00 AM UTC
Immunicon received a $100,000 Phase I SBIR grant from the National Cancer Institute to develop technologies for analyzing circulating cancer cells in the peripheral blood of patients with early-stage ...